Stanley C. Erck - 26 Sep 2022 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role: President and CEO, Director
Signature: /s/ John A. Herrmann III, Attorney-in-Fact
Issuer symbol: NVAX
Transactions as of: 26 Sep 2022
Net transactions value: -$41,137
Form type: 4
Filing time: 28 Sep 2022, 17:02:58 UTC
Previous filing: 08 Jul 2022
Next filing: 16 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVAX	Common Stock	Options Exercise		+6,546	+24%		34,026	26 Sep 2022	Direct	F1
transaction	NVAX	Common Stock	Tax liability	$41,137	-2,180	-6.4%	$18.87	31,846	26 Sep 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Restricted Stock Units	Options Exercise	$0	-6,546	-100%	$0.000000^*	0	26 Sep 2022	Common Stock	6,546		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2	The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date, in each case subject to continued employment through such vesting date.